These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9723384)

  • 1. Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients.
    Varghese Z; Fernando RL; Turakhia G; Psimenou E; Brunton C; Fernando ON; Davenport A; Burns A; Sweny P; Powis SH; Moorhead JF
    Transplant Proc; 1998 Aug; 30(5):2043-6. PubMed ID: 9723384
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-density lipoprotein composition and oxidation are not influenced by calcineurin inhibitors in renal transplant patients.
    Morena M; Vela C; Garrigue V; Catanzano J; Descomps B; Cristol JP; Mourad G
    Transplant Proc; 2000 Dec; 32(8):2785-6. PubMed ID: 11134805
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
    Claesson K; Mayer AD; Squifflet JP; Grabensee B; Eigler FW; Behrend M; Vanrenterghem Y; van Hooff J; Morales JM; Johnson RW; Buchholz B; Land W; Forsythe JL; Neumayer HH; Ericzon BG; Mühlbacher F
    Transplant Proc; 1998 Jun; 30(4):1292-4. PubMed ID: 9636524
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
    Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
    Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients.
    Varghese Z; Fernando RL; Turakhia G; Psimenou E; Fernando ON; Sweny P; Powis SH; Moorhead JF
    Kidney Int Suppl; 1999 Jul; 71():S137-40. PubMed ID: 10412758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.
    Jensik SC
    Transplant Proc; 1998 Jun; 30(4):1216-8. PubMed ID: 9636494
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxidation of low-density lipoproteins in renal transplant recipients.
    Cofan F; Zambon D; Rodriguez C; Laguna JC; Vazquez M; Casals E; Torregrosa J; Ros E; Oppenheimer F
    Transplant Proc; 1999 Sep; 31(6):2333-4. PubMed ID: 10500604
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
    Friemann S; Feuring E; Padberg W; Ernst W
    Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F; Cofan M; Campos B; Guerra R; Campistol JM; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
    Martínez Castelao A; Ramos R; Serón D; Gil-Vernet S; Fiol C; Gómez-Gerique N; Yzaguirre MT; Hurtado I; Sabaté I; Alsina J; Grinyó JM
    Nefrologia; 2002; 22(4):364-9. PubMed ID: 12369128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-center comparison between primary immunosuppression based on neoral cyclosporine and tacrolimus for renal transplantation.
    Pascual J; Marcén R; Burgos FJ; Tenorio MT; Merino JL; Arambarri M; Villafruela JJ; Liaño F; Mampaso F; Ortuño J
    Transplant Proc; 2002 Feb; 34(1):94-5. PubMed ID: 11959200
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
    Jurewicz WA
    Transplant Proc; 1999 Nov; 31(7A):64S-66S. PubMed ID: 10576048
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatty acid composition in low-density lipoproteins from renal transplant recipients.
    Cofan F; Zambon D; Rodriguez C; Laguna JC; Vazquez M; Casals E; Torregrosa J; Ros E; Oppenheimer F
    Transplant Proc; 1999 Sep; 31(6):2330-2. PubMed ID: 10500603
    [No Abstract]   [Full Text] [Related]  

  • 14. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
    Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
    Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S; Demers P; St-Louis G; Boily JG; Tousignant J; Lemieux F; Smeesters C; Corman J; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidation of low-density lipoproteins in renal transplant recipients treated with tacrolimus.
    Cofan F; Zambon D; Laguna JC; Ros E; Casals E; Cofan M; Campistol JM; Oppenheimer F
    Transplant Proc; 2002 Feb; 34(1):377-8. PubMed ID: 11959335
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid profile during azathioprine or mycophenolate mofetil combinations with cyclosporine and steroids.
    Akman B; Uyar M; Afsar B; Sezer S; Ozdemir FN; Haberal M
    Transplant Proc; 2007; 39(1):135-7. PubMed ID: 17275490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study.
    Squifflet JP; Vanrenterghem Y; van Hooff JP; Salmela K; Rigotti P;
    Transplant Proc; 2002 Aug; 34(5):1584-6. PubMed ID: 12176495
    [No Abstract]   [Full Text] [Related]  

  • 19. One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation.
    Campos HH; Abbud Filho M;
    Transplant Proc; 2002 Aug; 34(5):1656-8. PubMed ID: 12176523
    [No Abstract]   [Full Text] [Related]  

  • 20. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.